4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-020547
Chief Operating Officer bought 36,000 shares at an average $0.91 ($32,894)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/rdgdoc.xml…